And theyre not for everyone. The key update On December 20, 2024 , the FDA approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity , to be used in combination with a reduced-calorie diet and increased physical activity
The table below outlines the commonly recommended Wegovy pill doses when changing from Mounjaro treatment
According to the FDA labels for Mounjaro and Zepbound, gastrointestinal adverse reactions are generally mild to moderate in severity and often decrease over time, but individualized assessment is essential
Storing lyophilized powder (pre-reconstitution) Unreconstituted lyophilized tirzepatide is remarkably stable
International Journal of Molecular Sciences , 22 (12), 6623
Consistent with previous results, several review articles and meta-analyses reported beneficial effects of L-carnitine supplementation on mortality and cardiovascular outcomes in cardiac patients (AlMosawi 2021